AIM’s Latest Newsletter: The Research Edition, July 2023
Published:
08/01/2023

This month’s newsletter focuses on the latest news and scientific breakthroughs in melanoma research.
This edition features:
- Letter from AIM’s President, Sam Guild
- Notes From the Lab: Novel Targets for Immune Checkpoint Inhibitors
By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory - In Plain English: Neoadjuvant Therapy for Melanoma, and How We Got Here
By Kim Margolin, M.D., FACP, FASCO - Clinical Trials Catch Up: An Interview with Joshua M.V. Mammen, M.D., Ph.D., F.A.C.S.
By Alicia Rowell, Vice President, AIM at Melanoma
Recent Posts

Jul. 01, 2025
A Conversation with Dr. Rena Szabo, PsyD on Empowering Patients

Jun. 18, 2025
Empowering Women in Melanoma: A Look Inside the Women in Melanoma Initiative

Jun. 18, 2025
Melanoma News and Highlights You Don’t Want to Miss

Jun. 10, 2025
Coping with Cancer: DBT Skills for Emotional Resilience

Jun. 06, 2025